Harrow completes $30M acquisition of TYRVAYA nasal spray

🌐 Investing.com (Cyprus) — 2026-10-05

Harrow completed a $30 million acquisition of TYRVAYA, a nasal spray used in eye care. The headline does not provide further details about the transaction or product rights.

Markets Deals Health Harrow TYRVAYA acquisition nasal spray ophthalmology

Read original source →

Abia encourages local participation for two international events
Punch Nigeria — 2026-10-07
‘Why S’East needs digital transformation to drive growth’
Punch Nigeria — 2026-10-07
NNPC: People, discipline and strategy behind profit numbers
Punch Nigeria — 2026-10-07
Ex-CIA official with gold, cash stash pleads guilty to fraud
Punch Nigeria — 2026-10-06
Mexico’s fixed capital investment grew 6% in July, the fastest pace in 2 years
The News Mexico — 2026-10-06
SOHAR Port and Freezone appoints new CEO
Container News — 2026-10-06

Harrow completes $30M acquisition of TYRVAYA nasal spray

AI Summary

Related Articles

Abia encourages local participation for two international events

‘Why S’East needs digital transformation to drive growth’

NNPC: People, discipline and strategy behind profit numbers

Ex-CIA official with gold, cash stash pleads guilty to fraud

Mexico’s fixed capital investment grew 6% in July, the fastest pace in 2 years

SOHAR Port and Freezone appoints new CEO